Dekabank Deutsche Girozentrale Adds $135K in Covista Inc. ($CVSA)
Key Points
- Wall Street's consensus rating on $CVSA is Strong Buy and an average price target of $156.25.
- $CVSA last traded around $131.89.
Dekabank Deutsche Girozentrale acquired a new position in Covista Inc. ($CVSA), according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,022 shares of Covista Inc.. Dekabank Deutsche Girozentrale's holdings in Covista Inc. were worth $134,792 as of its most recent filing.
Covista Inc. ($CVSA) Stock
Covista Inc. Earnings
Analysts Set New Price Targets
About Covista Inc.
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.